AI matches your cancer tests to possible treatment trials
Part of Blood & lymphatic, Brain & nervous system, Cancer, Digestive system, Ear, nose & throat, Hormones & metabolism, Immune system & allergy, Kidney & urinary, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.
This trial uses an AI system to help match people with certain cancer types and specific tumor test results (like gene or protein markers) to relevant clinical trials. It may help you and your doctor find studies that fit your cancer biology faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer that is either solid (a tumor) or blood cancer
- Your tumor tests show specific markers (such as PD-L1 or MSI/MMR or others listed), from approved lab testing
- Your care team (and possibly you) agrees to do a trial pre-screening check
- Your current overall health/activity level is not worse than ECOG 0–2
- Your organs (such as liver, kidneys, etc.) work well enough for research participation
- You are not enrolled in hospice care
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an AI system that helps doctors find clinical trials for cancer patients whose disease has worsened. It uses electronic health records to suggest trial options, aiming to make it easier for patients to access new treatments.
This Phase 2 trial matches people with advanced cancer to a targeted treatment based on a genetic (DNA) or protein (IHC) test from their tumor. It’s for cancers that are no longer responding to standard treatment or where no standard option is available.
This trial tests cancer drugs that are already approved for other cancers, chosen based on specific changes found in your tumor. It may help people whose cancer is growing despite standard treatment (or who no longer have standard options).
This trial tests a non-invasive, AI-based monitoring program for people with solid tumors. It aims to help track how you’re doing during or after curative-intent treatment, using information collected without extra procedures.
This early-phase study tests whether a personalized cancer treatment plan based on your tumor’s test results can help people with aggressive cancers that are hard to treat. It may be an option if standard treatments didn’t work, aren’t possible for you, or you have few treatment choices.
This study looks at the genes in your cancer to find a treatment that might work better for you. It tests your tumor sample to match you with a drug that targets your cancer's specific weaknesses.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.